Sarah Kleinpeter is a seasoned pharmaceutical executive with extensive experience in developing and launching new medicines globally. With 17 years in the industry, they have held various leadership roles, including Vice President and General Manager at LEO Pharma, where they led a cultural and performance transformation. Currently, Sarah serves as the SVP for Alzheimer's and Dementia Franchise at Biogen, following their role as Global Vice President at Novo Nordisk. Their career has encompassed significant advancements in R&D, commercialization, and patient care strategies across multiple therapy areas and international markets. Sarah holds a Master's degree in Analytical Chemistry from the University of the Sciences in Philadelphia.
This person is not in any teams
This person is not in any offices